Multiple Myeloma Latest Advances

Cost-effectiveness analysis of elranatamab versus physician's choice of treatment (non-BCMA-directed regimens) in patients with triple class exposed multiple myeloma in Japan.

Journal: Journal of medical economics

Published: September 08, 2026

Chinese expert consensus on infection management in multiple myeloma patients treated with bispecific antibody (2026)

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Predictive value of next-generation sequencing-based measurable residual disease quantitative stratification for early disease progression in newly diagnosed multiple myeloma after induction therapy

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Efficacy and safety of oral melphalan as conditioning regimen for autologous hematopoietic stem cell transplantation in multiple myeloma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

The correlation between lymphocyte subsets before autologous hematopoietic stem cell transplantation and hematopoietic reconstruction and recurrence after transplantation in multiple myeloma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Impact of the infused CD34(+) cell dose on hematopoietic reconstitution and transplant-related outcomes in newly diagnosed multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Journal: Leukemia & lymphoma

Published: September 06, 2026

Monoclonal Gammopathy with Double M-bands Mimicking Biclonal Gammopathy: A Case Series.

Journal: EJIFCC

Published: September 05, 2026

Newest glue degrader nabs multiple myeloma approval.

Journal: Nature reviews. Drug discovery

Published: September 05, 2026

Bisalbuminemia: A Rare Finding Identified via Serum Protein Agarose Gel Electrophoresis and Capillary Electrophoresis Techniques.

Journal: EJIFCC

Published: September 05, 2026

Integrating Palliative Care into Relapsed/Refractory Multiple Myeloma in the Immunotherapy Era: A Narrative Review.

Journal: Journal of pain & palliative care pharmacotherapy

Published: September 04, 2026

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.

Journal: Hematology/oncology clinics of North America

Published: September 02, 2026

Multiple Myeloma Latest Advances

Find the Latest Research About Multiple Myeloma

Cost-effectiveness analysis of elranatamab versus physician's choice of treatment (non-BCMA-directed regimens) in patients with triple class exposed multiple myeloma in Japan.

Cost-effectiveness analysis of elranatamab versus physician's choice of treatment (non-BCMA-directed regimens) in patients with triple class exposed multiple myeloma in Japan.

Chinese expert consensus on infection management in multiple myeloma patients treated with bispecific antibody (2026)

Chinese expert consensus on infection management in multiple myeloma patients treated with bispecific antibody (2026)

Predictive value of next-generation sequencing-based measurable residual disease quantitative stratification for early disease progression in newly diagnosed multiple myeloma after induction therapy

Predictive value of next-generation sequencing-based measurable residual disease quantitative stratification for early disease progression in newly diagnosed multiple myeloma after induction therapy

Efficacy and safety of oral melphalan as conditioning regimen for autologous hematopoietic stem cell transplantation in multiple myeloma

Efficacy and safety of oral melphalan as conditioning regimen for autologous hematopoietic stem cell transplantation in multiple myeloma

The correlation between lymphocyte subsets before autologous hematopoietic stem cell transplantation and hematopoietic reconstruction and recurrence after transplantation in multiple myeloma

The correlation between lymphocyte subsets before autologous hematopoietic stem cell transplantation and hematopoietic reconstruction and recurrence after transplantation in multiple myeloma

Impact of the infused CD34(+) cell dose on hematopoietic reconstitution and transplant-related outcomes in newly diagnosed multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

Impact of the infused CD34(+) cell dose on hematopoietic reconstitution and transplant-related outcomes in newly diagnosed multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.

Monoclonal Gammopathy with Double M-bands Mimicking Biclonal Gammopathy: A Case Series.

Monoclonal Gammopathy with Double M-bands Mimicking Biclonal Gammopathy: A Case Series.

Newest glue degrader nabs multiple myeloma approval.

Newest glue degrader nabs multiple myeloma approval.

Bisalbuminemia: A Rare Finding Identified via Serum Protein Agarose Gel Electrophoresis and Capillary Electrophoresis Techniques.

Bisalbuminemia: A Rare Finding Identified via Serum Protein Agarose Gel Electrophoresis and Capillary Electrophoresis Techniques.

Integrating Palliative Care into Relapsed/Refractory Multiple Myeloma in the Immunotherapy Era: A Narrative Review.

Integrating Palliative Care into Relapsed/Refractory Multiple Myeloma in the Immunotherapy Era: A Narrative Review.

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.

Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.